We have detected that you are using some form of ad-blocking or filtering.
Please consider white-listing Labnodes since 1) ad-blockers like uBlock break Labnodes functionality and 2) Labnodes does not serve ads.
, a bio/informatics shared resource is still "open for business" - Visit the CDS website
Type 1 and Type 2 Diabetes Nephropathy Study
The purpose of this study is to determine study drug effectiveness in the treatment of diabetic nephropathy.
To qualify to participate:
How to Participate
To participate, contact Jonathan Williams at (615) 875-9200 or e-mail at email@example.com
© 2010-2020. All Rights Reserved to Vanderbilt University. Vanderbilt University is committed to principles of equal opportunity and affirmative action.
Released February 29, 2020